Carboplatin plus etoposide in heavily pretreated castration-resistant prostate cancer patients.
Buonerba C, Federico P, Bosso D, Puglia L, Policastro T, Izzo M, Perri F, Vittoria Scarpati GD, Ferro M, Cobelli OD, De Placido S, Aieta M, Imbimbo C, Longo N, Di Lorenzo G.
Buonerba C, et al.
Future Oncol. 2014 Jun;10(8):1353-60. doi: 10.2217/fon.14.71.
Future Oncol. 2014.
PMID: 25052746
Clinical Trial.